Market Research Reports, Inc.

Drug Discovery Outsourcing Global Market - Forecast to 2022, New Report Launched

Market Research Reports, Inc. has announced the addition of “Drug Discovery Outsourcing Global Market - Forecast To 2022” research report to their website


Lewes, DE -- (SBWIRE) -- 01/20/2016 -- Over the last two decades, the Pharmaceutical/Biotech industry has undergone radical changes. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift towards biologics have seen a surge in the externalization and outsourcing activities. As the industry is looking for new sources of discovery and innovation with limited resources, there is a growing preference to move towards externalization and willingness to embrace the concept of outsourcing, Publisher estimates that ~15% of the pharmaceutical/biotech R&D spending goes into drug discovery.

Almost all the major Pharmaceutical/biotech companies are considering outsourcing as a core strategy to fill their discovery pipelines. Outsourcing companies that have precise capabilities through greater flexibility are the preferred ones. Now-a-days, the big pharma relies more on CRO's for drug discovery capabilities to stock up their pipelines

The global pharmaceutical outsourcing market was estimated to be $XX billion in 2015 and of that a little less than fifty percent accounted for CRO's. Publisher estimates that the global drug discovery based services to be $XX billion in 2015 and rest accounts for biology-related service and clinical services. Current R&D outsourcing penetration is estimated to be ~ X percent of the global pharmaceutical and biotech industry spending but poised to grow at CAGR of X% percent in the coming years.

This report provides comprehensive insights on the global drug discovery outsourcing market. The report covers all segments, global trends and emerging strategies of the outsourcing market related to drug discovery. Major Drug Discovery Outsourcing (DDO) players included in the report are Evotec, Charles River Laboratories (CRL), Pharmaceutical Product Development (PPD), WuxiApptec, ChemPartner, Syngene, Aurigene, Jubilant Biosys, Advinus, GVK Biosciences, TCG Lifesciences and AMRI.

This report caters to the need of Contract research organizations, Pharmaceutical/Biotech companies, Academic institutes, Individual researchers, Investors, Service providers and other associated stake holders to identify and analyze the potential of the DDO market. The report also provides insights on customer base, number of deals between CRO's and Pharmaceutical /biotech firms, global FTE rates, employee strength & number of companies, revenue per employee of major players, therapeutic area gap analysis and successful research collaboration outcomes of selected CRO's and Sponsors, which are likely to have an impact on the DDO market in the foreseeable future.

This report covers in-depth analysis of major players by therapeutic area of focus, capabilities, geographic presence, business models, financials, collaborations, acquisitions, various marketing strategies adopted along with insightful analysis on conferences, clusters and match making websites.

Spanning over 182 pages "Drug Discovery Outsourcing Global Market - Forecast To 2022" report covers Introduction, Market Analysis, Business Overview, Competitor Analysis, Leading Players, Marketing Strategies. The report covered companies are - Advinus, Amri Global, Aurigene, Charles River Laboratories (Crl), Chempartner, Evotec, Gvk Biosciences, Jubilant Biosys, Pharmaceutical Product Development (Ppd), Syngene, Tcg Lifesciences, Wuxiapptec

For more information Visit at:

Find all Drug Discovery report at:

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Yearly/Quarterly Report Subscription: